Evidence Supports Adding Biological, Pathological, and Molecular Assessments to the TNM Lung Cancer Staging System
Beth Fand IncollingoA presentation at the 2022 European Lung Cancer Congress convinced attendees that the current system for staging lung cancer needs refinement. Read more
Renowned Researcher Fred Hirsch Delivers 2022 Heine H. Hansen Award Lecture
Erin JungmeyerThe honor of giving the opening keynote address during ELCC recognizes Dr. Hirsch’s significant contributions to international research and education. Read more
In Brief for May 25, 2022
Erin Jungmeyer5th edition of patient education book released; US FDA moves to prohibit tobacco flavoring. Read more
Financial Toxicity of Lung Cancer in the Netherlands
Anne-Marie C. Dingemans, MD, PhD+more
Even when treatment costs are covered, the majority of lung cancer patients experience increased expenses and/or reduced income following their diagnoses. Read more
A real-world look at diagnostic-therapeutic pathways explores how they may help provide optimal, innovative care without ballooning costs. Read more
Small, High PLCG2-Expressing Intratumoral Cells May Drive Metastasis
Alvaro Quintanal-Villalonga, PhD+more
In the search to understand the mechanisms of metastasis, researchers have expanded the spectrum of SCLC clinical specimens amenable for single-cell resolution analysis. Read more
COAST Data Support Further Research of Immunotherapy Combinations
Mariona Riudavets, MD, PhD+more
Trial is the first to show improved efficacy and a manageable safety profile after cCRT in unresectable locally advanced stage III NSCLC regardless of PD-L1 status. Read more
IASLC Responds to Call for Evidence
Erin JungmeyerThe association strongly recommends Europe include low-dose CT in revised screening recommendations. Read more
Winship Cancer Institute announces preceptor opportunity. NICE recommends tepotinib for select patients. Read more
TIL Therapy Endures for Carefully Selected Patients: A Q&A with Dr. Benjamin C. Creelan
Joy CurzioDr. Benjamin C. Creelan shares his passion for cell therapy research and insights into current data. Read more